| 摘要 |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: group of inventions relates to compositions causing specific response of cytotoxic T-lymphocytes (CTL) against T-cell epitopes in mammal organism, which include lymphopenia-causing compound, molecule possessing selective affinity to specialised antigen-presenting cells (APC), where said molecule is bound with said T-cell epitope, and, possibly, pharmaceutically acceptable carrier. Compositions can also contain adjuvant. ^ EFFECT: by means of compositions achieved are efficient anti-infection or anti-tumour actions. ^ 20 cl, 10 dwg, 2 tbl, 2 ex |
